<i>Letter to the Editor:</i> Repurposing of an Antisepsis Drug in COVID-19 Patients.

Kumar, Ashutosh; Pareek, Vikas; Kant, Kamla

Letter to the Editor: Repurposing of an Antisepsis Drug in COVID-19 Patients.

Kumar, Ashutosh; Pareek, Vikas; Kant, Kamla.

Kumar A; Etiologically Elusive Disorders Research Network (EEDRN), New Delhi, India.
Pareek V; Department of Anatomy, All India Institute of Medical Sciences (AIIMS), Patna, India.
Kant K; Etiologically Elusive Disorders Research Network (EEDRN), New Delhi, India.

Assay Drug Dev Technol ; 19(7): 407, 2021 10.

Article in English | MEDLINE | ID: covidwho-560032

Subject(s)

Anti-Infective Agents, Local/therapeutic use; COVID-19 Drug Treatment; Mycobacterium; Antiviral Agents; COVID-19/complications; Clinical Trials as Topic; Cytokine Release Syndrome/drug therapy; Cytokine Release Syndrome/etiology; Drug Repositioning; Humans

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Drug Treatment / Anti-Infective Agents, Local / Mycobacterium Type of study: Prognostic study / Randomized controlled trials Topics: Long Covid Limits: Humans Language: English Journal: Assay Drug Dev Technol Journal subject: Pharmacology Year: 2021 Document Type: Article Affiliation country: Adt.2020.994

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google